InventorsAssigneeUS Classes514/317, Additional ring containing514/446, Chalcogen bonded directly to ring sulfur by nonionic bonding514/473, Chalcogen bonded directly to the hetero ring514/718, Plural oxygens546/216, Chalcogen bonded directly to ring carbon of the piperidine ring549/62, Chalcogen bonded directly to ring carbon of the hetero ring549/475, Chalcogen bonded directly to the hetero ring568/662PolyoxyAttorney, Agent or FirmInternational Class 07 A61K031/445 A61K031/381 Issued Patent Number:7179800
Abstract textCompounds of the formula: wherein R, R1 and R4 are defined in the specification, and pharmaceutically acceptable salts, esters and tautomers thereof, having activity at peripheral cannabinoid receptors, commonly designated the CB2 receptor class. The compounds are useful for therapy, especially in the treatment of pain, inflammation and autoimmune disease. | 
